Okyo Pharma appointed Robert J. Dempsey to serve as the company’s next CEO, according to a press release.Dempsey has more than 20 years of experience in global ophthalmology and has held leadership roles at several companies. As group vice president an…
BARCELONA–(BUSINESS WIRE)–SpliceBio, una empresa de medicamentos genéticos en fase clínica pionera en el empalme de proteínas para tratar enfermedades causadas por mutaciones en genes grandes, ha anunciado hoy el nombramiento de Don Muñoz como direct…
At OSN New York, Healio | OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, and a panel of experts examined a series of unusual complications that occurred after routine refractive procedures.The panel broke down how to address antibioti…
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, announced that based on preliminary estimates …
TAMPA, Fla.–(BUSINESS WIRE)–Lions World Vision Institute (LWVI) broke ground on its new $16 million Vision Health Center in Tampa’s historic Ybor City.
BARCELONA–(BUSINESS WIRE)–SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced the appointment of Don Munoz as Chief Financial Officer. Mr. Munoz, wh…